Zivo Bioscience, Inc. (ZIVO)
6.50
-0.01
(-0.21%)
USD |
OTCM |
Oct 16, 16:00
Zivo Bioscience Net Income (Quarterly) : -0.5125M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5125M |
| March 31, 2026 | -0.9515M |
| December 31, 2025 | -3.008M |
| September 30, 2025 | -1.033M |
| June 30, 2025 | -1.640M |
| March 31, 2025 | -4.211M |
| December 31, 2024 | -1.601M |
| September 30, 2024 | -2.269M |
| June 30, 2024 | -8.236M |
| March 31, 2024 | -1.278M |
| December 31, 2023 | -1.908M |
| September 30, 2023 | -1.825M |
| June 30, 2023 | -2.071M |
| March 31, 2023 | -1.973M |
| December 31, 2022 | -2.641M |
| September 30, 2022 | -2.004M |
| June 30, 2022 | -2.072M |
| March 31, 2022 | -2.028M |
| December 31, 2021 | -3.265M |
| September 30, 2021 | -1.552M |
| June 30, 2021 | -1.846M |
| March 31, 2021 | -2.219M |
| December 31, 2020 | -1.893M |
| September 30, 2020 | -3.503M |
| June 30, 2020 | -1.167M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.543M |
| December 31, 2019 | -4.132M |
| September 30, 2019 | -1.781M |
| June 30, 2019 | -2.540M |
| March 31, 2019 | -3.057M |
| December 31, 2018 | -3.097M |
| September 30, 2018 | -4.119M |
| June 30, 2018 | -3.573M |
| March 31, 2018 | -3.846M |
| December 31, 2017 | -3.880M |
| September 30, 2017 | -2.868M |
| June 30, 2017 | -1.428M |
| March 31, 2017 | -1.862M |
| December 31, 2016 | -1.232M |
| September 30, 2016 | -1.140M |
| June 30, 2016 | -2.294M |
| March 31, 2016 | -1.393M |
| December 31, 2015 | -1.018M |
| September 30, 2015 | -1.475M |
| June 30, 2015 | -2.010M |
| March 31, 2015 | -1.287M |
| December 31, 2014 | 0.7263M |
| September 30, 2014 | -3.340M |
| June 30, 2014 | -0.6675M |
| March 31, 2014 | 3.962M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| PMGC Holdings, Inc. | -2.959M |
| Shonghoya Intl Group, Inc. | 0.00 |
| TFA Therapeutics, Inc. | -- |
| Arcadia Biosciences, Inc. | -6.266M |
| CCA Industries, Inc. | -0.1657M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.5125M |
| EPS Diluted (Quarterly) | -0.1235 |
| Enterprise Value | 27.85M |
| Earnings Yield | -21.63% |
| Normalized Earnings Yield | -21.65 |